New Delhi, May 13 -- A hormonal condition that affects 1 in 8 women worldwide has a new name to improve care. It is now called Polyendocrine Metabolic Ovarian Syndrome (PMOS) instead of Polycystic Ovary Syndrome (PCOS). Researchers and supporters of this change believe that the old name was misleading, arguing that it oversimplified a complex hormonal disorder by focusing too much on cysts and ovaries. This misunderstanding has led to many cases of missed diagnoses and inadequate treatment, according to the Endocrine Society, a global group of doctors and scientists.

The news about PCOS being re-termed PMOS was published first in The Lancet. Dr Melanie Cree, a pediatric endocrinology expert at the University of Colorado Anschutz and one ...